Gastrointestinal Cancers: Fine-Tuning the Management of Rectal, Esophageal, and Pancreas Cancers

Jeffrey R. Olsen(University of Colorado Denver), Salma K. Jabbour(Rutgers, The State University of New Jersey), Christopher L. Hallemeier(Mayo Clinic in Arizona), Smith Apisarnthanarax(University of Washington), Diana Tait(Royal Marsden NHS Foundation Trust), James D. Murphy(University of California San Diego), F. Huguet(Sorbonne Université)
International Journal of Radiation Oncology*Biology*Physics
August 15, 2019
10.1016/j.ijrobp.2019.04.037
Cited by 2

Related Papers

Cholangiocarcinoma — evolving concepts and therapeutic strategies
|Nature Reviews Clinical Oncology|2017|1.7k
Factors Predicting Response, Perioperative Outcomes, and Survival Following Total Neoadjuvant Therapy for Borderline/Locally Advanced Pancreatic Cancer
|Annals of Surgery|2019|445
Clinical Features and Outcome in North American Adults With Moyamoya Phenomenon
|Stroke|2006|337
Adaptive Radiation Therapy (ART) Strategies and Technical Considerations: A State of the ART Review From NRG Oncology
|International Journal of Radiation Oncology*Biology*Physics|2020|314
Oesophageal cancer
|The Lancet|2024|265